Evidence map›Paper›PMID 31183946›Full record

ArticleBritish journal of health psychology2019

Psychological correlates of adherence to photoprotection in a rare disease: International survey of people with Xeroderma Pigmentosum.

Jessica Walburn, Martha Canfield, Sam Norton, Kirby Sainsbury, Vera Araújo-Soares, Lesley Foster, Mark Berneburg, Alain Sarasin, Natalie Morrison-Bowen, Falko F Sniehotta and 2 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of health psychology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Jessica WalburnSchool of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, UK.ORCID 0000-0001-7396-0182
Martha CanfieldHealth Psychology Section, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Sam NortonHealth Psychology Section, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Kirby SainsburyFaculty of Medical Sciences, Institute of Health and Society, Newcastle University, UK.
Vera Araújo-SoaresFaculty of Medical Sciences, Institute of Health and Society, Newcastle University, UK.
Lesley FosterNational Xeroderma Pigmentosum Service, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
Mark BerneburgDepartment of Dermatology, Universitätsklinikum Regensburg, Germany.
Alain SarasinInstitute of Cancer and Genetics, Gustave Roussy Institute, UMR8200 CNRS, Villejuif, France.
Natalie Morrison-BowenSchool of Medicine, University of Leeds, UK.
Falko F SniehottaFaculty of Medical Sciences, Institute of Health and Society, Newcastle University, UK.
Robert SarkanyNational Xeroderma Pigmentosum Service, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
John WeinmanSchool of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, UK.
King's College London · GBNewcastle University · GBGuy's and St Thomas' NHS Foundation Trust · GBCentre National de la Recherche Scientifique · FRUniversity Hospital Regensburg · DEUniversity of Leeds · GB

Funding

Department of Health RP-PG-1212-20009
6 · The paper itself

Abstract

objectivesXeroderma pigmentosum (XP) is an extremely rare genetic disorder (approximately 100 known cases in the United Kingdom), where DNA damage caused by ultraviolet radiation in daylight cannot be repaired. Adherence to photoprotection is essential to prevent skin cancer. We investigated psychological correlates of photoprotection in the XP population of Western Europe and the United States.

designCross-sectional survey of adults with XP and caregivers of patients <16 years and those with cognitive impairment in the United Kingdom, Germany, the United States, and France (n = 156).

methodsPhotoprotection activities to protect the face and body when outdoors; avoidance of going outside during daylight hours; intention; self-efficacy; and social support were assessed using measures developed for this study. Participants answered questions about their illness representations of XP (BIPQ); beliefs about photoprotection (BMQ); automaticity (i.e., without conscious effort) (SRBAI); clinical and demographic characteristics. Ordinal logistic regressions determined factors associated with photoprotection.

resultsOne third did not achieve optimal face photoprotection. After controlling for demographic and clinical factors, modifiable correlates of higher photoprotection included greater perceived control of XP, stronger beliefs in necessity and effectiveness of photoprotection, and higher intention. Avoidance of going outside was associated with greater photoprotection concerns, more serious illness consequences, and higher XP-related distress. Greater automaticity and higher self-efficacy were associated with better protection across all outcomes.

conclusionsApproximately half of all known cases across three European countries participated. Identified modifiable predictors of photoprotection may be targeted by interventions to reduce the incidence of skin cancers in the immediate future, when a treatment breakthrough is unlikely. Statement of contribution What is already known on this subject? Adherence to photoprotection in other populations at elevated risk from skin cancer is poor; however, the level in XP is unknown. Research across chronic conditions shows that adherence to treatment and lifestyle recommendations are influenced by illness perceptions, self-efficacy, and treatment beliefs. Studies on photoprotection conducted with the general population have found that perceived risk, perceptions of ultraviolet radiation (UVR) protection, self-efficacy for the behaviour, and automaticity (behaviours that are enacted with little conscious awareness) are related to better photoprotection. What does this study add? This is the first international survey to examine adherence and its correlates in people with XP (an under-researched group at very high risk of fatal skin cancer). Adherence varies and at least one third have potential for improvement. Perceptions about XP, photoprotection beliefs, self-efficacy, intention, and automaticity were associated with photoprotection of the face and body when outdoors. Negative emotional representations of XP were associated with avoidance of going outside during daylight hours.

Indexed as

Radiation ProtectionSelf EfficacySkin NeoplasmsUltraviolet RaysXeroderma PigmentosumAdultCross-Sectional StudiesEuropeFemaleGermanyHealth BehaviorHumansIncidenceMaleRare DiseasesSurveys and Questionnairesadherenceillness perceptionsphotoprotectiontreatment beliefsXeroderma Pigmentosum

Identifiers

PMID31183946
PMCPMC6772157
OpenAlexW2952501266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.